RBTT-07. NUTMEG: A RANDOMISED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM): TRIAL IN PROGRESS

BACKGROUND: An increase of mutations as we age is well documented in GBM and in cancer in general. Elderly patients with GBM may have higher mutational burden and may be more likely to respond to immunotherapies. NUTMEG is a randomised Phase II study comparing post radiation NivolUmab and TMZ versus...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neuro Oncol
Prif Awduron: Khasraw, Mustafa, McDonald, Kerrie, Yip, Sonia, Verhaak, Roel, Heimberger, Amy, Hall, Merryn, Fisher, Lauren, Barnes, Elizabeth, Rosenthal, Mark, Gedye, Craig, Hovey, Elizabeth, Ellingson, Benjamin, Simes, John, Tognela, Annette, Koh, Eng-Siew, Gan, Hui, Back, Michael, Lwin, Zarnie
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2018
Pynciau:
Abstracts
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6217643/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.976
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg